» Articles » PMID: 37655009

Editorial: Neurological Comorbidity in Metabolic Syndrome

Overview
Journal Front Neurosci
Date 2023 Sep 1
PMID 37655009
Authors
Affiliations
Soon will be listed here.
References
1.
Zhu G, Zhao J, Zhang H, Chen W, Wang G . Probiotics for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis. Foods. 2021; 10(7). PMC: 8303183. DOI: 10.3390/foods10071672. View

2.
Whitmer R, Sidney S, SELBY J, Johnston S, Yaffe K . Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64(2):277-81. DOI: 10.1212/01.WNL.0000149519.47454.F2. View

3.
Stanciu G, Bild V, Ababei D, Rusu R, Cobzaru A, Paduraru L . Link Between Diabetes and Alzheimer's Disease due to the Shared Amyloid Aggregation and Deposition Involving both Neurodegenerative Changes and Neurovascular Damages. J Clin Med. 2020; 9(6). PMC: 7357086. DOI: 10.3390/jcm9061713. View

4.
Etchegoyen M, Nobile M, Baez F, Posesorski B, Gonzalez J, Lago N . Metabolic Syndrome and Neuroprotection. Front Neurosci. 2018; 12:196. PMC: 5919958. DOI: 10.3389/fnins.2018.00196. View

5.
Yaffe K, Bahorik A, Hoang T, Forrester S, Jacobs Jr D, Lewis C . Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA Study. Neurology. 2020; 95(7):e839-e846. PMC: 7605504. DOI: 10.1212/WNL.0000000000010078. View